490 related articles for article (PubMed ID: 31102936)
1. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
Chen J; Zhao D; Meng Q
Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
3. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
4. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.
Wu Y; Yang J; Zhang H; Cheng J; Lei P; Huang J
Horm Metab Res; 2024 May; 56(5):392-399. PubMed ID: 38052232
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
Yin D; Lu X
Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
Yan P; Su Z; Zhang Z; Gao T
Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
[TBL] [Abstract][Full Text] [Related]
11. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p.
Chen S; Ren C; Zheng H; Sun X; Dai J
Med Sci Monit; 2020 May; 26():e921383. PubMed ID: 32357145
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.
Chen Y; Zhang X; An Y; Liu B; Lu M
Mol Cell Endocrinol; 2020 Mar; 503():110697. PubMed ID: 31891769
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR‑135a‑mediated c‑myc activation.
Wang Y; Hou Z; Li D
Mol Med Rep; 2018 Sep; 18(3):3068-3076. PubMed ID: 30015867
[TBL] [Abstract][Full Text] [Related]
16. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.
Zhang W; Ji W; Zhao X
BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
[TBL] [Abstract][Full Text] [Related]
17. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
Zhang Y; Li K; Wang W; Han J
Int J Exp Pathol; 2021 Aug; 102(4-5):209-217. PubMed ID: 34719830
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC00313 Knockdown Inhibits Tumorigenesis and Metastasis in Human Osteosarcoma by Upregulating FOSL2 through Sponging miR-342-3p.
Chen H; Wahafu P; Wang L; Chen X
Yonsei Med J; 2020 May; 61(5):359-370. PubMed ID: 32390359
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β-catenin/cyclin D1 signaling via PLAGL2.
Liu Q; Ran R; Song M; Li X; Wu Z; Dai G; Xia R
Cell Biol Toxicol; 2022 Dec; 38(6):979-993. PubMed ID: 34331612
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p.
Luo M; Liang C
Biol Res; 2020 Apr; 53(1):14. PubMed ID: 32293550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
